MedPath

Nutrition Optimalization Among Pregnant Women to Improve Maternal and Neonatal Outcome in DKI Jakarta

Not Applicable
Recruiting
Conditions
Preterm Birth
Neonatal Death
IUGR
Asphyxia Neonatorum
Maternal Death
Preeclampsia
Low; Birthweight, Extremely (999 Grams or Less)
Pregnancy Complications
Intrauterine Infection
Pregnancy Hemorrhage
Registration Number
NCT06268509
Lead Sponsor
Dr Cipto Mangunkusumo General Hospital
Brief Summary

The goal of this MONAS Study is to learn about comprehensive monitoring and nutritional intervention among pregnant women in order to improve maternal and neonatal outcomes. The main questions it aims to answer are:

1. Are comprehensive monitoring and nutritional intervention among pregnant women can improve maternal outcomes (maternal death, preterm labour, preeclampsia, intrauterine infection, and bleeding during pregnancy and delivery) compared to standard maternal health services?

2. Are comprehensive monitoring and nutritional intervention among pregnant women can improve neonatal outcomes (neonatal death, low birth weight, intrauterine growth restriction, and neonatal asphyxia) compared to standard maternal health services?

Participants in the intervention group will receive:

* Fetomaternal ultrasound examination each trimester

* Complete laboratory examination for nutritional panel (complete blood count with reticulocyte profile and iron profile, vitamin D level, zinc level, fatty acid profile, electrophoresis for Thalassemia) as an addition to standard maternal routine laboratory examination

* Supplements: multivitamin, minerals, vitamin D, fatty acid

* Intervention regarding any abnormal results of nutritional panel

* All standard maternal health services according to Indonesian Ministry of Health protocol

Participants in the control group will receive:

- All standard maternal health services according to Indonesian Ministry of Health protocol

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
245
Inclusion Criteria
  • Pregnancy in 1st trimester
  • Gestational age less than 10 weeks
  • Living in Jakarta greater area
  • Agree to participate
Exclusion Criteria
  • Assisted reproductive technology (IVF)
  • History of polycystic ovary syndrome
  • History of chronic hypertension
  • History of diabetes mellitus
  • History of preeclampsia in the previous pregnancy
  • Had chronic disease: heart disease, autoimmune disease, malignancy, chronic lung disease
  • Planning to have delivery outside Jakarta greater area
  • Poor obstetric history (miscarriage/ abortion more than 3 times)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Composite of poor maternal outcomesAt anytime between 20 weeks of gestational age until 28 days after delivery

Number of participants with a combination of maternal death, preterm labour, preeclampsia, intrauterine infection, and bleeding during pregnancy and or after delivery

Composite of poor neonatal outcomesAfter delivery of participants (any gestational age) until 28 days of chronological age

A number of baby born from participants with a combination of neonatal death, low birth weight, intrauterine growth restriction, neonatal asphyxia, and need of admission to intensive care untill 28 daya of age

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Jakarta Primary Care Health Facility (Puskesmas) under Jakarta Health Office

🇮🇩

Jakarta, Indonesia

Jakarta Primary Care Health Facility (Puskesmas) under Jakarta Health Office
🇮🇩Jakarta, Indonesia
Risal, M.D., M.Sc.
Contact
dinkes@jakarta.go.id

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.